
Telmitop AMH 40mg/5mg/12.5mg Tablet
Marketer
Zoic Lifesciences
Salt Composition
Telmisartan (40mg) + Amlodipine (5mg) + Hydrochlorothiazide (12.5mg)
Overview Telmitop AMH 40mg/5mg/12.5mg Tablet
Amlodipine/Hydrochlorothiazide/Telmisartan 40mg/5mg/12.5mg tablets offer a combined approach to managing hypertension when monotherapy proves insufficient. This medication lowers elevated blood pressure, consequently reducing the risk of future strokes and heart attacks. The tablets may be taken with or without food, at the same time daily, as directed by your physician. Consistent use is vital, ceasing only upon your doctor's instruction. As it includes a diuretic, increased urination is expected; avoid dosing within four hours of bedtime. Regular use, even during periods of well-being, maximizes therapeutic effects. Hypertension is often asymptomatic, and discontinuation elevates stroke and heart attack risk. Common side effects may encompass headache, fatigue, dizziness, altered taste, flu-like symptoms, diarrhea, and sinus inflammation. Report any persistent, worsening, or bothersome side effects to your doctor. Maintain adequate hydration to mitigate potential dryness, thirst, and muscle weakness. Prior to commencing treatment, inform your doctor about existing kidney or liver conditions, pregnancy, breastfeeding, and all other medications, particularly those for cardiovascular issues. Regular monitoring of blood pressure, kidney function, electrolyte levels, and blood glucose is necessary to ensure optimal efficacy and safety.
Uses of Telmitop AMH 40mg/5mg/12.5mg Tablet
Elevated arterial blood pressure
Major Benefits of Telmitop AMH 40mg/5mg/12.5mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Telmitop AMH 40mg/5mg/12.5mg Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Telmitop AMH 40mg/5mg/12.5mg Tablet:
- Dizziness
- Nausea
- Peripheral edema
- Flu-like symptoms
- Diarrhea
- Upper respiratory tract infection
- Visual disturbance
How to use Telmitop AMH 40mg/5mg/12.5mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Telmitop AMH 40mg/5mg/12.5mg Tablets can be consumed with or without food, though consistent timing is recommended for optimal results.
How Telmitop AMH 40mg/5mg/12.5mg Tablet works:
Telmisartan, Amlodipine, and Hydrochlorothiazide (40mg/5mg/12.5mg) combined in Telmitop AMH tablets, manage hypertension through a three-pronged approach. Telmisartan, an angiotensin II receptor antagonist, and Amlodipine, a calcium channel blocker, both promote vasodilation, reducing blood pressure. Hydrochlorothiazide, a diuretic, further lowers blood pressure by increasing urinary excretion of water and electrolytes, and also contributes to vasodilation and improved circulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Telmitop AMH 40mg/5mg/12.5mg tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
Use of Telmitop AMH 40mg/5mg/12.5mg tablets during pregnancy poses a confirmed risk to fetal development and is therefore inadvisable. Exceptions may be made in life-threatening circumstances where a physician determines the potential benefits outweigh the known hazards. Always seek medical advice before taking this medication.
Breast feedingUNSAFE
Lactation and Telmitop AMH 40mg/5mg/12.5mg tablets are incompatible. Evidence indicates potential infant harm from this medication.
DrivingUNSAFE
Driving ability may be impaired by side effects of Telmitop AMH 40mg/5mg/12.5mg Tablets. These potential side effects include dizziness, headaches, nausea, and fatigue, all of which can reduce concentration and driving aptitude.
KidneyCAUTION
Patients with severe kidney impairment should use Telmitop AMH 40mg/5mg/12.5mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. Telmitop AMH 40mg/5mg/12.5mg tablets are generally unsuitable for individuals with severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Telmitop AMH 40mg/5mg/12.5mg tablets cautiously, as dose modification may be necessary. Physician consultation is advised.
What if you forget to take Telmitop AMH 40mg/5mg/12.5mg Tablet :
Should you forget a Telmitop AMH 40mg/5mg/12.5mg Tablet dose, administer it immediately upon remembrance. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Telmitop AMH 40mg/5mg/12.5mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Heart |
